Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transmyocardial laser revascularization.

Keith A Horvath1

  • 1Cardiothoracic Surgery Research, National Heart, Lung and Blood Institute/NIH, Bethesda, Maryland 20892, USA. khorvath@nih.gov

Journal of Cardiac Surgery
|April 26, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Program Directors' Assessments of US Medical Graduates' Transition to Residency.

JAMA network open·2025
Same author

What value do teaching hospitals provide commercial beneficiaries when in an ACO?

The American journal of managed care·2024
Same author

Who participates in value-based care models? Physician characteristics and implications for value-based care.

Health affairs scholar·2024
Same author

Trends in sepsis and pneumonia during COVID-19: lessons from BPCIA.

The American journal of managed care·2023
Same author

Succeeding in Medicare's newest bundled payment program: Results from teaching hospitals.

Healthcare (Amsterdam, Netherlands)·2022
Same author

Evaluating the Addition of Clinical and Staging Data to Improve the Pricing Methodology of the Oncology Care Model.

JCO oncology practice·2022
Same journal

Erratum.

Journal of cardiac surgery·2023
Same journal

Validity of direct bilateral axillary arterial cannulation in emergency surgery for acute type A aortic dissection.

Journal of cardiac surgery·2023
Same journal

Evaluation of midterm outcomes after Shone's complex surgery: Analysis of reoperation and mortality risk factors.

Journal of cardiac surgery·2023
Same journal

Subannular procedures on papillary muscles for secondary mitral valve regurgitation repair.

Journal of cardiac surgery·2022
Same journal

Safety of apixaban and rivaroxaban compared to warfarin after cardiac surgery.

Journal of cardiac surgery·2022
Same journal

Impact of rapid rehabilitation surgery on perioperative nursing in patients undergoing cardiac surgery: A meta-analysis.

Journal of cardiac surgery·2022
See all related articles

Transmyocardial laser revascularization (TMR) offers significant angina relief for patients with severe coronary artery disease. Combining TMR with coronary artery bypass grafting (CABG) improves symptoms without increasing risk, potentially through enhanced angiogenesis.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Regenerative Medicine

Background:

  • Transmyocardial laser revascularization (TMR) has been clinically available for nearly a decade.
  • Initial studies demonstrated TMR safety as a standalone treatment for severe angina.
  • Randomized controlled trials confirmed TMR efficacy in patients with diffuse coronary disease unsuitable for conventional revascularization.

Purpose of the Study:

  • To evaluate the efficacy and safety of Transmyocardial Laser Revascularization (TMR).
  • To assess the benefits of TMR as an adjunct to Coronary Artery Bypass Grafting (CABG).
  • To explore the angiogenic mechanisms and future therapeutic enhancements for TMR.

Main Methods:

  • Nonrandomized studies initially assessed TMR safety.

Related Experiment Videos

  • Multiple randomized controlled trials (RCTs) were conducted to prove TMR efficacy.
  • Clinical data analyzed outcomes of combined CABG + TMR therapy.

    • Main Results:

    • TMR demonstrated significant angina relief compared to maximum medical therapy.
    • Combined CABG + TMR therapy in patients with severe coronary disease and comorbidities resulted in symptomatic improvement.
    • No additional risk was observed with the combination therapy.

    Conclusions:

    • Transmyocardial laser revascularization (TMR) is an effective treatment for severe angina in specific patient populations.
    • Combining TMR with CABG offers symptomatic benefits without increased risk for complex cases.
    • The primary mechanism of TMR benefit is likely laser-induced angiogenesis, with potential for enhancement via stem cell therapies.